The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Advisory Committee (PAC) and the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC). This meeting was announced in the Federal Register of January 23, 2018. The amendment is being made to reflect a change in the agenda for the open session of the meeting and to extend the amount of time allotted for the closed session. There are no other changes.
Document
Pediatric Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice
The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Pediatric Advisory Committee (PAC) and the Endocrinologic and Metabolic Drugs A...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
83 FR 11755
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Pediatric Advisory Committee and the Endocrinologic and Metabolic Drugs Advisory Committee; Amendment of Notice,” thefederalregister.org (March 16, 2018), https://thefederalregister.org/documents/2018-05413/pediatric-advisory-committee-and-the-endocrinologic-and-metabolic-drugs-advisory-committee-amendment-of-notice.